-
1
-
-
80052769870
-
Molecular oncology of lung cancer
-
Toyooka S., Mitsudomi T., Soh J., Aokage K., Yamane M., Oto T., et al. Molecular oncology of lung cancer. Gen Thorac Cardiovasc Surg 2011, 59:527-537.
-
(2011)
Gen Thorac Cardiovasc Surg
, vol.59
, pp. 527-537
-
-
Toyooka, S.1
Mitsudomi, T.2
Soh, J.3
Aokage, K.4
Yamane, M.5
Oto, T.6
-
2
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
Gurubhagavatula, S.4
Okimoto, R.A.5
Brannigan, B.W.6
-
3
-
-
2342624080
-
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
-
Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
-
(2004)
Science
, vol.304
, pp. 1497-1500
-
-
Paez, J.G.1
Janne, P.A.2
Lee, J.C.3
Tracy, S.4
Greulich, H.5
Gabriel, S.6
-
4
-
-
20044364940
-
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
-
Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba I.I., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005, 97:339-346.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 339-346
-
-
Shigematsu, H.1
Lin, L.2
Takahashi, T.3
Nomura, M.4
Suzuki, M.5
Wistuba, I.I.6
-
5
-
-
33744814638
-
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors
-
Politi K., Zakowski M.F., Fan P.D., Schonfeld E.A., Pao W., Varmus H.E. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev 2006, 20:1496-1510.
-
(2006)
Genes Dev
, vol.20
, pp. 1496-1510
-
-
Politi, K.1
Zakowski, M.F.2
Fan, P.D.3
Schonfeld, E.A.4
Pao, W.5
Varmus, H.E.6
-
6
-
-
0012381722
-
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial)
-
Fukuoka M., Yano S., Giaccone G., Tamura T., Nakagawa K., Douillard J.Y., et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol 2003, 21:2237-2246.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2237-2246
-
-
Fukuoka, M.1
Yano, S.2
Giaccone, G.3
Tamura, T.4
Nakagawa, K.5
Douillard, J.Y.6
-
7
-
-
19944433797
-
The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers
-
Tokumo M., Toyooka S., Kiura K., Shigematsu H., Tomii K., Aoe M., et al. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 2005, 11:1167-1173.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1167-1173
-
-
Tokumo, M.1
Toyooka, S.2
Kiura, K.3
Shigematsu, H.4
Tomii, K.5
Aoe, M.6
-
8
-
-
20244388126
-
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence
-
Mitsudomi T., Kosaka T., Endoh H., Horio Y., Hida T., Mori S., et al. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol 2005, 23:2513-2520.
-
(2005)
J Clin Oncol
, vol.23
, pp. 2513-2520
-
-
Mitsudomi, T.1
Kosaka, T.2
Endoh, H.3
Horio, Y.4
Hida, T.5
Mori, S.6
-
9
-
-
75249087060
-
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
-
Mitsudomi T., Morita S., Yatabe Y., Negoro S., Okamoto I., Tsurutani J., et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 2010, 11:121-128.
-
(2010)
Lancet Oncol
, vol.11
, pp. 121-128
-
-
Mitsudomi, T.1
Morita, S.2
Yatabe, Y.3
Negoro, S.4
Okamoto, I.5
Tsurutani, J.6
-
10
-
-
77953930730
-
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR
-
Maemondo M., Inoue A., Kobayashi K., Sugawara S., Oizumi S., Isobe H., et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010, 362:2380-2388.
-
(2010)
N Engl J Med
, vol.362
, pp. 2380-2388
-
-
Maemondo, M.1
Inoue, A.2
Kobayashi, K.3
Sugawara, S.4
Oizumi, S.5
Isobe, H.6
-
11
-
-
70349591635
-
Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment
-
Jida M., Toyooka S., Mitsudomi T., Takano T., Matsuo K., Hotta K., et al. Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment. Cancer Sci 2009, 100:1931-1934.
-
(2009)
Cancer Sci
, vol.100
, pp. 1931-1934
-
-
Jida, M.1
Toyooka, S.2
Mitsudomi, T.3
Takano, T.4
Matsuo, K.5
Hotta, K.6
-
12
-
-
0037333520
-
The relationship between aging and carcinogenesis: a critical appraisal
-
Anisimov V.N. The relationship between aging and carcinogenesis: a critical appraisal. Crit Rev Oncol Hematol 2003, 45:277-304.
-
(2003)
Crit Rev Oncol Hematol
, vol.45
, pp. 277-304
-
-
Anisimov, V.N.1
-
13
-
-
31544459265
-
Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay
-
Asano H., Toyooka S., Tokumo M., Ichimura K., Aoe K., Ito S., et al. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 2006, 12:43-48.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 43-48
-
-
Asano, H.1
Toyooka, S.2
Tokumo, M.3
Ichimura, K.4
Aoe, K.5
Ito, S.6
-
14
-
-
33745985181
-
A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer
-
Yatabe Y., Hida T., Horio Y., Kosaka T., Takahashi T., Mitsudomi T. A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. J Mol Diagn 2006, 8:335-341.
-
(2006)
J Mol Diagn
, vol.8
, pp. 335-341
-
-
Yatabe, Y.1
Hida, T.2
Horio, Y.3
Kosaka, T.4
Takahashi, T.5
Mitsudomi, T.6
-
15
-
-
78650477805
-
Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancer
-
Choi Y.H., Lee J.K., Kang H.J., Lee T.S., Kim H.R., Kim C.H., et al. Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancer. J Thorac Oncol 2010, 5:1949-1952.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 1949-1952
-
-
Choi, Y.H.1
Lee, J.K.2
Kang, H.J.3
Lee, T.S.4
Kim, H.R.5
Kim, C.H.6
-
16
-
-
61549091557
-
Prognostic implication of EGFR KRAS and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma
-
Kosaka T., Yatabe Y., Onozato R., Kuwano H., Mitsudomi T. Prognostic implication of EGFR KRAS and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol 2009, 4:22-29.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 22-29
-
-
Kosaka, T.1
Yatabe, Y.2
Onozato, R.3
Kuwano, H.4
Mitsudomi, T.5
-
17
-
-
40049100818
-
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
-
Marks J.L., Broderick S., Zhou Q., Chitale D., Li A.R., Zakowski M.F., et al. Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma. J Thorac Oncol 2008, 3:111-116.
-
(2008)
J Thorac Oncol
, vol.3
, pp. 111-116
-
-
Marks, J.L.1
Broderick, S.2
Zhou, Q.3
Chitale, D.4
Li, A.R.5
Zakowski, M.F.6
-
18
-
-
34547638047
-
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
-
Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
-
(2007)
Nature
, vol.448
, pp. 561-566
-
-
Soda, M.1
Choi, Y.L.2
Enomoto, M.3
Takada, S.4
Yamashita, Y.5
Ishikawa, S.6
-
19
-
-
63949087355
-
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
-
Inamura K., Takeuchi K., Togashi Y., Hatano S., Ninomiya H., Motoi N., et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol 2009, 22:508-515.
-
(2009)
Mod Pathol
, vol.22
, pp. 508-515
-
-
Inamura, K.1
Takeuchi, K.2
Togashi, Y.3
Hatano, S.4
Ninomiya, H.5
Motoi, N.6
-
20
-
-
36549083391
-
Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations
-
Marusyk A., DeGregori J. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim Biophys Acta 2008, 1785:1-11.
-
(2008)
Biochim Biophys Acta
, vol.1785
, pp. 1-11
-
-
Marusyk, A.1
DeGregori, J.2
-
21
-
-
0028053024
-
K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location
-
Breivik J., Meling G.I., Spurkland A., Rognum T.O., Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer 1994, 69:367-371.
-
(1994)
Br J Cancer
, vol.69
, pp. 367-371
-
-
Breivik, J.1
Meling, G.I.2
Spurkland, A.3
Rognum, T.O.4
Gaudernack, G.5
-
22
-
-
9944227795
-
Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC K-ras, and p53 genes
-
Chiang J.M., Wu Chou Y.H., Ma S.C., Chen J.R. Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC K-ras, and p53 genes. Virchows Arch 2004, 445:465-471.
-
(2004)
Virchows Arch
, vol.445
, pp. 465-471
-
-
Chiang, J.M.1
Wu Chou, Y.H.2
Ma, S.C.3
Chen, J.R.4
-
23
-
-
0035887141
-
Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort
-
Pollack I.F., Finkelstein S.D., Burnham J., Holmes E.J., Hamilton R.L., Yates A.J., et al. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res 2001, 61:7404-7407.
-
(2001)
Cancer Res
, vol.61
, pp. 7404-7407
-
-
Pollack, I.F.1
Finkelstein, S.D.2
Burnham, J.3
Holmes, E.J.4
Hamilton, R.L.5
Yates, A.J.6
-
24
-
-
0037220167
-
The TP53 gene, tobacco exposure, and lung cancer
-
Toyooka S., Tsuda T., Gazdar A.F. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 2003, 21:229-239.
-
(2003)
Hum Mutat
, vol.21
, pp. 229-239
-
-
Toyooka, S.1
Tsuda, T.2
Gazdar, A.F.3
-
25
-
-
0030056868
-
Differences in lung cancer risk between men and women: examination of the evidence
-
Zang E.A., Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996, 88:183-192.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 183-192
-
-
Zang, E.A.1
Wynder, E.L.2
|